Skip to content

Restricted Cash at other companies

Embecta Corp. logo
Embecta Corp.EMBC
$8.5M+183%
Owlet logo
OwletOWLT
$5.55M+1,750%
DexCom logo
DexComDXCM
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Reported directly by Senseonics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's restricted cash?
Senseonics Holdings, Inc. (SENS) reported restricted cash of $315K in Q1 2026.
How has Senseonics Holdings, Inc. 's restricted cash changed year-over-year?
Senseonics Holdings, Inc. 's restricted cash decreased by 0.0% year-over-year, from $315K to $315K.
What is the long-term trend for Senseonics Holdings, Inc. 's restricted cash?
Over 2 years (2020 to 2025), Senseonics Holdings, Inc. 's restricted cash has grown at a 25.5% compound annual growth rate (CAGR), from $200K to $315K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.